<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">evrazkar</journal-id><journal-title-group><journal-title xml:lang="ru">Евразийский Кардиологический Журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Eurasian heart journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2225-1685</issn><issn pub-type="epub">2305-0748</issn><publisher><publisher-name>Евразийская ассоциация кардиологов</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.38109/2225-1685-2021-1-6-43</article-id><article-id custom-type="elpub" pub-id-type="custom">evrazkar-6253</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ РЕКОМЕНДАЦИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL GUIDELINES</subject></subj-group></article-categories><title-group><article-title>ЕВРАЗИЙСКИЕ РЕКОМЕНДАЦИИ ПО ДИАГНОСТИКЕ И ЛЕЧЕНИЮ ХРОНИЧЕСКОЙ ТРОМБОЭМБОЛИЧЕСКОЙ ЛЕГОЧНОЙ ГИПЕРТЕНЗИИ (2020)</article-title><trans-title-group xml:lang="en"><trans-title>EURASIAN ASSOCIATION OF CARDIOLOGY (EAC) GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (2020)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9822-4357</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чазова</surname><given-names>И. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Chazova</surname><given-names>I. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>зам. генерального директора по научно-экспертной работе, руководитель отдела гипертонии, акад. РАН, профессор, д.м.н., президент Евразийской ассоциации кардиологов и Российского медицинского общества по артериальной гипертонии</p><p>Москва</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9022-8097</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мартынюк</surname><given-names>Т. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Martynyuk</surname><given-names>T. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>руководитель отдела легочной гипертензии и заболеваний сердца;</p><p>проф. кафедры кардиологии, д.м.н.;</p><p>председатель секции легочной гипертензии Российского медицинского общества по артериальной гипертонии</p><p>121552, Москва, ул. 3-я Черепковская, д. 15а, телефон/факс: +7-495-414-6450</p></bio><bio xml:lang="en"><p>MD, PhD, DMSc, Main Researcher, Head of the Department of Pulmonary Hypertension and Heart Diseases</p><p>3rd Cherepkovskaya street, 15a, Moscow 121552, Russia, Phone/Fax +7-495-414-6450</p></bio><email xlink:type="simple">trukhiniv@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9041-3604</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Валиева</surname><given-names>З. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Valieva</surname><given-names>Z. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>старший научный сотрудник отдела легочной гипертензии и заболеваний сердца, к.м.н</p><p>Москва</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5655-3913</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Азизов</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Azizov</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>заведующий кафедрой внутренних болезней, профессор, д.м.н.</p><p>Баку</p></bio><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6726-4612</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Акчурин</surname><given-names>Р. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Akchurin</surname><given-names>R. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>руководитель отдела сердечно-сосудистой хирургии, акад. РАН, проф., д.м.н.</p><p>Москва</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2675-3276</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Аншелес</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Ansheles</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>старший научный сотрудник отдела радионуклидной диагностики и ПЭТ, д.м.н.</p><p>Москва</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2932-3159</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Васильцева</surname><given-names>О. Я.</given-names></name><name name-style="western" xml:lang="en"><surname>Vasiltseva</surname><given-names>O. Ya.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ведущий научный сотрудник центра хирургии аорты, коронарных и периферических артерий, д.м.н., проф.</p><p>Новосибирск</p></bio><xref ref-type="aff" rid="aff-5"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8319-3714</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Веселова</surname><given-names>Т. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Veselova</surname><given-names>T. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>старший научный сотрудник отдела томографии, д.м.н.</p><p>Москва</p></bio><xref ref-type="aff" rid="aff-6"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4510-6197</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Галявич</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Galyavich</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>заведующий кафедрой кардиологии, вице-президент Российского кардиологического общества, профессор, д.м.н., главный кардиолог Приволжского ФО</p><p>Казань</p></bio><xref ref-type="aff" rid="aff-7"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4193-3320</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Горбачевский</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Gorbachevsky</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>руководитель отдела заболеваний сердца с прогрессирующей легочной гипертензией;</p><p>профессор кафедры сердечно-сосудистой хирургии, профессор, д.м.н.</p><p>Москва</p></bio><xref ref-type="aff" rid="aff-8"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9853-9087</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Данилов</surname><given-names>Н. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Danilov</surname><given-names>N. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ведущий научный сотрудник отдела гипертонии, д.м.н.</p><p>Москва</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6661-7826</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Едемский</surname><given-names>А. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Edemskiy</surname><given-names>A. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>сердечно-сосудистый хирург центра хирургии аорты, коронарных и периферических артерий, к.м.н.</p><p>Новосибирск</p></bio><xref ref-type="aff" rid="aff-5"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6513-6772</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зелвеян</surname><given-names>П. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Zelveyan</surname><given-names>P. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>директор, главный кардиолог г. Еревана, президент Армянской медицинской ассоциации, профессор, д.м.н.</p><p>Ереван</p></bio><xref ref-type="aff" rid="aff-9"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3818-7491</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лазарева</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Lazareva</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>зав. отделением, к.м.н.</p><p>Минск</p></bio><xref ref-type="aff" rid="aff-10"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0200-852X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Матчин</surname><given-names>Ю. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Matchin</surname><given-names>Yu. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>руководитель лаборатории рентгенэндоваскулярных методов диагностики и лечения в амбулаторных условиях, проф., д.м.н.</p><p>Москва</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7256-0563</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мершин</surname><given-names>К. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Mershin</surname><given-names>K. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н. врач-хирург отдела сердечно-сосудистой хирургии</p><p>Москва</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2854-1952</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мукаров</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Mukarov</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>зав. отделением, к.м.н.</p><p>Нур-Султан</p></bio><xref ref-type="aff" rid="aff-11"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1564-7619</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Наконечников</surname><given-names>С. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Nakonechnikov</surname><given-names>S. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>директор Российского медицинского общества по артериальной гипертонии, проф. кафедры кардиологии</p><p>Москва</p></bio><xref ref-type="aff" rid="aff-12"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3233-1862</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Саидова</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Saidova</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>руководитель отдела ультразвуковой диагностики, профессор, д.м.н.</p><p>Москва</p></bio><xref ref-type="aff" rid="aff-6"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2172-9776</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сарыбаев</surname><given-names>А. Ш.</given-names></name><name name-style="western" xml:lang="en"><surname>Sarybaev</surname><given-names>A. Sh.</given-names></name></name-alternatives><bio xml:lang="ru"><p>директор, профессор, д.м.н.</p><p>Бишкек</p></bio><xref ref-type="aff" rid="aff-13"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0487-6902</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сергиенко</surname><given-names>В. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Sergienko</surname><given-names>V. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>руководитель отдела радионуклидной диагностики и ПЭТ, профессор, д.м.н.</p><p>Москва</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8377-2388</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Стукалова</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Stukalova</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>старший научный сотрудник отдела томографии, к.м.н.</p><p>Москва</p></bio><xref ref-type="aff" rid="aff-14"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7688-7176</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Филиппов</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Filippov</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>заведующий кафедрой поликлинической терапии и профилактической медицины, д.м.н., главный кардиолог Рязанской области</p><p>Рязань</p></bio><xref ref-type="aff" rid="aff-15"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9818-8678</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чернявский</surname><given-names>А. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Chernyavsky</surname><given-names>A. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>генеральный директор Центра хирургии аорты, коронарных и периферических артерий, д.м.н., проф.</p><p>Новосибирск</p></bio><xref ref-type="aff" rid="aff-16"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1214-0150</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чернявский</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Chernyavsky</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>заведующий НИО сосудистой и интервенционной хирургии, главный научный сотрудник, сердечно-сосудистый хирург, д.м.н.</p><p>Санкт-Петербург</p></bio><xref ref-type="aff" rid="aff-17"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2724-4016</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шалаев</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Shalaev</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>заведующий кафедрой, заслуженный деятель науки РФ, профессор, д.м.н., главный специалист-кардиолог департамента здравоохранения Тюменской области, главный кардиолог Уральского ФО</p><p>Тюмень</p></bio><xref ref-type="aff" rid="aff-18"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8937-1796</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шмальц</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Shmalts</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ведущий научный сотрудник отдела заболеваний сердца с прогрессирующей легочной гипертензией;</p><p>доцент кафедры сердечно-сосудистой хирургии, д.м.н.</p><p>Москва</p></bio><xref ref-type="aff" rid="aff-8"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>ФГБУ «НМИЦ кардиологии» Минздрава России</institution><country>Russian Federation</country></aff><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>НИИ клинической кардиологии им. А.Л. Мясникова ФГБУ «НМИЦ кардиологии» Минздрава России;&#13;
ФДПО РНИМУ им. Н.И. Пирогова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Medical Research Center of Cardiology</institution><country>Russian Federation</country></aff></aff-alternatives><aff xml:lang="ru" id="aff-3"><institution>НИИ клинической кардиологии им. А.Л. Мясникова ФГБУ «НМИЦ кардиологии» Минздрава России</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-4"><institution>Азербайджанский медицинский университет</institution><country>Azerbaijan</country></aff><aff xml:lang="ru" id="aff-5"><institution>ФГБУ «НМИЦ им. ак. Е.Н. Мешалкина» Минздрава России</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-6"><institution>НИИ кардиологии им. А.Л. Мясникова ФГБУ «НМИЦ кардиологии» Минздрава России</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-7"><institution>Казанский государственный медицинский университет</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-8"><institution>ФГБУ «НМИЦ ССХ им. А.Н. Бакулева» МЗ РФ;&#13;
ФГБОУ ДПО РМАНПО МЗ РФ</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-9"><institution>Центр превентивной Кардиологии</institution><country>Armenia</country></aff><aff xml:lang="ru" id="aff-10"><institution>Республиканский научно-практический центр Кардиология</institution><country>Belarus</country></aff><aff xml:lang="ru" id="aff-11"><institution>Национальный научный кардиохирургический центр</institution><country>Kazakhstan</country></aff><aff xml:lang="ru" id="aff-12"><institution>ФДПО РНИМУ им. Н.И. Пирогова</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-13"><institution>Национальный центр кардиологии и терапии им. академика М. Миррахимова при Минздраве Кыргызской Республики</institution><country>Kyrgyzstan</country></aff><aff xml:lang="ru" id="aff-14"><institution>НИИ кардиологии им. А.Л. Мясникова</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-15"><institution>Рязанский Государственный Медицинский Университет</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-16"><institution>ФГБУ «Новосибирский научно-исследовательский институт патологии кровообращения им. ак. Е.Н. Мешалкина» Минздрава России</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-17"><institution>ФГБУ «НМИЦ им. Алмазова» МЗ РФ</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-18"><institution>департамент здравоохранения Тюменской области</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>30</day><month>03</month><year>2021</year></pub-date><volume>0</volume><issue>1</issue><fpage>6</fpage><lpage>43</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Чазова И.Е., Мартынюк Т.В., Валиева З.С., Азизов В.А., Акчурин Р.С., Аншелес А.А., Васильцева О.Я., Веселова Т.Н., Галявич А.С., Горбачевский С.В., Данилов Н.М., Едемский А.Г., Зелвеян П.А., Лазарева И.В., Матчин Ю.Г., Мершин К.В., Мукаров М.А., Наконечников С.Н., Саидова М.А., Сарыбаев А.Ш., Сергиенко В.Б., Стукалова О.В., Филиппов Е.В., Чернявский А.М., Чернявский М.А., Шалаев С.В., Шмальц А.А., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Чазова И.Е., Мартынюк Т.В., Валиева З.С., Азизов В.А., Акчурин Р.С., Аншелес А.А., Васильцева О.Я., Веселова Т.Н., Галявич А.С., Горбачевский С.В., Данилов Н.М., Едемский А.Г., Зелвеян П.А., Лазарева И.В., Матчин Ю.Г., Мершин К.В., Мукаров М.А., Наконечников С.Н., Саидова М.А., Сарыбаев А.Ш., Сергиенко В.Б., Стукалова О.В., Филиппов Е.В., Чернявский А.М., Чернявский М.А., Шалаев С.В., Шмальц А.А.</copyright-holder><copyright-holder xml:lang="en">Chazova I.E., Martynyuk T.V., Valieva Z.S., Azizov V.A., Akchurin R.S., Ansheles A.A., Vasiltseva O.Y., Veselova T.N., Galyavich A.S., Gorbachevsky S.V., Danilov N.M., Edemskiy A.G., Zelveyan P.A., Lazareva I.V., Matchin Y.G., Mershin K.V., Mukarov M.A., Nakonechnikov S.N., Saidova M.A., Sarybaev A.S., Sergienko V.B., Stukalova O.V., Filippov E.V., Chernyavsky A.M., Chernyavsky M.A., Shalaev S.V., Shmalts A.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.heartj.asia/jour/article/view/6253">https://www.heartj.asia/jour/article/view/6253</self-uri><abstract><p>Отказ от ответственности. Рекомендации ЕАК отражают точку зрения ЕАК и были подготовлены после тщательного изучения научных и медицинских данных, имеющихся на момент их публикации. ЕАК не несут ответственности в случае какого-либо противоречия, несоответствия и / или неоднозначности между Рекомендациями ЕАК и любыми другими официальными рекомендациями или руководствами, выпущенными соответствующими органами общественного здравоохранения, в частности, в отношении правильного использования медицинских или терапевтических стратегий. Медицинским работникам рекомендуется в полной мере учитывать Рекомендации ЕАК при оценке своего клинического суждения, а также при определении и реализации профилактических, диагностических или терапевтических медицинских стратегий. Тем не менее, Рекомендации ЕАК никоим образом не отменяют индивидуальную ответственность медицинских работников за принятие надлежащих и точных решений с учетом состояния здоровья каждого пациента и в консультации с этим пациентом и, при необходимости и / или необходимости, опекуна пациента. Рекомендации ЕАК не освобождают медицинских работников от полного и тщательного рассмотрения соответствующих официальных обновленных рекомендаций или руководств, выпущенных компетентными органами общественного здравоохранения, для рассмотрения каждого медицинского случая в свете современных научно обоснованных рекомендаций в соответствии с их этическими и профессиональными обязательствами. Кроме того, медицинский работник обязан проверять действующие правила и положения, касающиеся лекарств и медицинских изделий, на момент назначения по рецепту.</p></abstract><trans-abstract xml:lang="en"><p>Disclaimer The EAC Guidelines represent the views of the EAC, and were produced after careful consideration of the scientific and medical knowledge, and the evidence available at the time of their publication. The EAC is not responsible in the event of any contradiction, discrepancy, and/or ambiguity between the EAC Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies. Health professionals are encouraged to take the EAC Guidelines fully into account when exercising their clinical judgment, as well as in the determination and the implementation of preventive, diagnostic, or therapeutic medical strategies; however, the EAC Guidelines do not override, in any way whatsoever, the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient’s health condition and in consultation with that patient and, where appropriate and/or necessary, the patient’s caregiver. Nor do the EAC Guidelines exempt health professionals from taking into full and careful consideration the relevant official updated recommendations or guidelines issued by the competent public health authorities, in order to manage each patient’s case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations. It is also the health professional’s responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>хроническая тромбоэмболическая легочная гипертензия</kwd><kwd>легочная эндартерэктомия</kwd><kwd>баллонная ангиопластика легочных артерий</kwd></kwd-group><kwd-group xml:lang="en"><kwd>chronic thromboembolic pulmonary hypertension</kwd><kwd>pulmonary endarterectomy</kwd><kwd>balloon pulmonary angioplasty</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Архипова О.А., Мартынюк Т.В., Самойленко Л.Е., др. Перфузионная сцинтиграфия легких у больных с легочной гипертензией различной этиологии. Евразийский кардиологический журнал 2015; 4: 21-25.</mixed-citation><mixed-citation xml:lang="en">Архипова О.А., Мартынюк Т.В., Самойленко Л.Е., др. Перфузионная сцинтиграфия легких у больных с легочной гипертензией различной этиологии. Евразийский кардиологический журнал 2015; 4: 21-25.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Белевская А.А., Дадачева З.Х., Саидова М.А., др. Возможности эхокардиографии в диагностике легочной гипертензии и оценке ремоделирования сердца. Лечебное дело. 2015; 1: 111-121.</mixed-citation><mixed-citation xml:lang="en">Белевская А.А., Дадачева З.Х., Саидова М.А., др. Возможности эхокардиографии в диагностике легочной гипертензии и оценке ремоделирования сердца. Лечебное дело. 2015; 1: 111-121.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Блинова Е.В., Сахнова Т.А., Мартынюк Т.В., др. Сопоставление векторкардиографических параметров со структурно-функциональным состоянием правого желудочка у пациентов с легочной гипертензией. Системные гипертензии. 2015; 4: 57-60.</mixed-citation><mixed-citation xml:lang="en">Блинова Е.В., Сахнова Т.А., Мартынюк Т.В., др. Сопоставление векторкардиографических параметров со структурно-функциональным состоянием правого желудочка у пациентов с легочной гипертензией. Системные гипертензии. 2015; 4: 57-60.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Данилов Н.М., Матчин Ю.Г., Чазова И.Е. Баллонная ангиопластика легочных артерий при неоперабельной хронической тромбоэмболической легочной гипертензии. Сonsilium Medicum 2016; 5: 59-61.</mixed-citation><mixed-citation xml:lang="en">Данилов Н.М., Матчин Ю.Г., Чазова И.Е. Баллонная ангиопластика легочных артерий при неоперабельной хронической тромбоэмболической легочной гипертензии. Сonsilium Medicum 2016; 5: 59-61.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Валиева З.С., Грацианская С.Е., Мартынюк Т.В. Применение риоцигуата для лечения пациентов с хронической тромбоэмболической легочной гипертензией. Кардиология 2020; 60 (8): 115-123. DOI: 10.18087/cardio.2020.8.n1198</mixed-citation><mixed-citation xml:lang="en">Валиева З.С., Грацианская С.Е., Мартынюк Т.В. Применение риоцигуата для лечения пациентов с хронической тромбоэмболической легочной гипертензией. Кардиология 2020; 60 (8): 115-123. DOI: 10.18087/cardio.2020.8.n1198</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Веселова Т.Н., Демченкова А.Ю., Мартынюк Т.В., др. Субтракционная КТ-ангиопульмонография в диагностике хронической тромбоэмболической легочной гипертензии. Медицинская визуализация 2018; 4: 40-49. doi.org/10.24835/1607-0763-2018-4-40-49</mixed-citation><mixed-citation xml:lang="en">Веселова Т.Н., Демченкова А.Ю., Мартынюк Т.В., др. Субтракционная КТ-ангиопульмонография в диагностике хронической тромбоэмболической легочной гипертензии. Медицинская визуализация 2018; 4: 40-49. doi.org/10.24835/1607-0763-2018-4-40-49</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Газизов В.В., Мершин К.В., Табакьян Е.А., др. Результаты легочной тромбэндартерэктомии в зависимости от величины легочного сосудистого сопротивления и ангиографического индекса поражения легочной артерии. Системные гипертензии 2020; 17 (1): 62-68. DOI: 10.26442/2075082X.2020.1.200040</mixed-citation><mixed-citation xml:lang="en">Газизов В.В., Мершин К.В., Табакьян Е.А., др. Результаты легочной тромбэндартерэктомии в зависимости от величины легочного сосудистого сопротивления и ангиографического индекса поражения легочной артерии. Системные гипертензии 2020; 17 (1): 62-68. DOI: 10.26442/2075082X.2020.1.200040</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Демченкова А.Ю., Веселова Т.Н., Мартынюк Т.В., др. Состояние сосудистого русла, паренхимы и перфузии легких при хронической тромбоэмболической легочной гипертензии по данным субтракционной компьютерной томографической ангиопульмонографии. Кардиология 2018; 58 (5): 48-56. doi.org/10.18087/cardio.2018.5.10120</mixed-citation><mixed-citation xml:lang="en">Демченкова А.Ю., Веселова Т.Н., Мартынюк Т.В., др. Состояние сосудистого русла, паренхимы и перфузии легких при хронической тромбоэмболической легочной гипертензии по данным субтракционной компьютерной томографической ангиопульмонографии. Кардиология 2018; 58 (5): 48-56. doi.org/10.18087/cardio.2018.5.10120</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Карабашева М.Б., Данилов Н.М., Сагайдак О.В., др. Отдаленные результаты ангиопластики легочных артерий у пациентов с неоперабельной ХТЭЛГ. Системные гипертензии 2019; 16 (4):27-32. DOI: 10.26442/2075082X.2019.4.190609</mixed-citation><mixed-citation xml:lang="en">Карабашева М.Б., Данилов Н.М., Сагайдак О.В., др. Отдаленные результаты ангиопластики легочных артерий у пациентов с неоперабельной ХТЭЛГ. Системные гипертензии 2019; 16 (4):27-32. DOI: 10.26442/2075082X.2019.4.190609</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Клименко А.А., Шостак Н.А., Демидова Н.А., Новиков И.В. Хроническая постэмболическая легочная гипертензия: новые аспекты формирования и прогрессирования заболевания. Клиницист 2011; 5 (1):14–17. doi.org/10.17650/1818-8338-2011-1-14-17</mixed-citation><mixed-citation xml:lang="en">Клименко А.А., Шостак Н.А., Демидова Н.А., Новиков И.В. Хроническая постэмболическая легочная гипертензия: новые аспекты формирования и прогрессирования заболевания. Клиницист 2011; 5 (1):14–17. doi.org/10.17650/1818-8338-2011-1-14-17</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Мартынюк Т.В., Чазова И.Е. Илопрост— ингаляционный аналог простациклина для лечения больных легочной гипертензией. Системные гипертензии 2011; 4: 57–63.</mixed-citation><mixed-citation xml:lang="en">Мартынюк Т.В., Чазова И.Е. Илопрост— ингаляционный аналог простациклина для лечения больных легочной гипертензией. Системные гипертензии 2011; 4: 57–63.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Мартынюк Т.В., Дадачева З.Х., Парамонов В.М., др. Применение ингибитора фосфодиэстеразы типа 5 силденафила у больных с легочной гипертензией. Евразийский кардиологический журнал 2015; 2: 42-49. eLIBRARY ID: 23754520</mixed-citation><mixed-citation xml:lang="en">Мартынюк Т.В., Дадачева З.Х., Парамонов В.М., др. Применение ингибитора фосфодиэстеразы типа 5 силденафила у больных с легочной гипертензией. Евразийский кардиологический журнал 2015; 2: 42-49. eLIBRARY ID: 23754520</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Мартынюк Т.В. Легочная гипертензия: Диагностика и лечение. Сер. Библиотека ФГБУ «НИМЦ кардиологии» Минздрава России.— М.: ООО «Медицинское информационное агентство». 2018. — 304 с. ISBN: 978-5-6040008-0-9</mixed-citation><mixed-citation xml:lang="en">Мартынюк Т.В. Легочная гипертензия: Диагностика и лечение. Сер. Библиотека ФГБУ «НИМЦ кардиологии» Минздрава России.— М.: ООО «Медицинское информационное агентство». 2018. — 304 с. ISBN: 978-5-6040008-0-9</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Мершин К.В., Акчурин Р.С. Хроническая тромбоэмболическая легочная гипертензия/ Глава в монографии «Легочная гипертензия» под ред. Чазовой И.Е., Мартынюк Т.В. — М: Практика. 2015. — С. 563–602. ISBN: 978-5-89816-138-5</mixed-citation><mixed-citation xml:lang="en">Мершин К.В., Акчурин Р.С. Хроническая тромбоэмболическая легочная гипертензия/ Глава в монографии «Легочная гипертензия» под ред. Чазовой И.Е., Мартынюк Т.В. — М: Практика. 2015. — С. 563–602. ISBN: 978-5-89816-138-5</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Мершина Е.А., Синицын В.Е. Роль методов лучевой диагностики при постановке диагноза хронической тромбоэмболической легочной гипертензии. Атеротромбоз 2016; 1: 16-25. doi.org/10.21518/2307-1109-2016-1-16-25</mixed-citation><mixed-citation xml:lang="en">Мершина Е.А., Синицын В.Е. Роль методов лучевой диагностики при постановке диагноза хронической тромбоэмболической легочной гипертензии. Атеротромбоз 2016; 1: 16-25. doi.org/10.21518/2307-1109-2016-1-16-25</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Рябыкина Г.В., Блинова Е.В., Сахнова Т.А. Электровекторкардиографическая диагностика гипертрофии правого желудочка у больных легочной гипертензией. Медицинский алфавит 2017; 8: 3-17. eLIBRARY ID: 32368029</mixed-citation><mixed-citation xml:lang="en">Рябыкина Г.В., Блинова Е.В., Сахнова Т.А. Электровекторкардиографическая диагностика гипертрофии правого желудочка у больных легочной гипертензией. Медицинский алфавит 2017; 8: 3-17. eLIBRARY ID: 32368029</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Сахнова Т.А., Блинова Е.В., Белевская А.А., др. Сопоставление интегральных показателей векторкардиограммы с данными эхокардиографического исследования у больных идиопатической и хронической тромбоэмболической легочной гипертензией. Терапевтический архив 2019; 3: 11-16. DOI: 10.26442/00403660.2019.03.000043</mixed-citation><mixed-citation xml:lang="en">Сахнова Т.А., Блинова Е.В., Белевская А.А., др. Сопоставление интегральных показателей векторкардиограммы с данными эхокардиографического исследования у больных идиопатической и хронической тромбоэмболической легочной гипертензией. Терапевтический архив 2019; 3: 11-16. DOI: 10.26442/00403660.2019.03.000043</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Таран И.Н., Белевская А.А., Валиева З.С., Саидова М.А., Мартынюк Т.В. «Портрет» пациентов с идиопатической легочной гипертензией и хронической тромбоэмболической легочной гипертензией в зависимости от коморбидного статуса: особенности течения заболевания и прогноз. Пульмонология. 2020;30(4) :427-36 DOI: 10.18093/0869-0189-2020-30-4-421-426</mixed-citation><mixed-citation xml:lang="en">Таран И.Н., Белевская А.А., Валиева З.С., Саидова М.А., Мартынюк Т.В. «Портрет» пациентов с идиопатической легочной гипертензией и хронической тромбоэмболической легочной гипертензией в зависимости от коморбидного статуса: особенности течения заболевания и прогноз. Пульмонология. 2020;30(4) :427-36 DOI: 10.18093/0869-0189-2020-30-4-421-426</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Чазова И.Е., Авдеев С.Н., Царева Н.А., др. Клинические рекомендации по диагностике и лечению легочной гипертонии. Терапевтический архив 2014; 9: 4-23. eLIBRARY ID: 22599889</mixed-citation><mixed-citation xml:lang="en">Чазова И.Е., Авдеев С.Н., Царева Н.А., др. Клинические рекомендации по диагностике и лечению легочной гипертонии. Терапевтический архив 2014; 9: 4-23. eLIBRARY ID: 22599889</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Чазова И.Е., Мартынюк Т.В., Филиппов Е.В., др. Клинические рекомендации по диагностике и лечению хронической тромбоэмболической легочной гипертензии. (I ЧАСТЬ). Терапевтический архив 2016; 88 (9): 90-101. DOI: 10.17116/terarkh201688990-101</mixed-citation><mixed-citation xml:lang="en">Чазова И.Е., Мартынюк Т.В., Филиппов Е.В., др. Клинические рекомендации по диагностике и лечению хронической тромбоэмболической легочной гипертензии. (I ЧАСТЬ). Терапевтический архив 2016; 88 (9): 90-101. DOI: 10.17116/terarkh201688990-101</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Чазова И.Е., Мартынюк Т.В., Филиппов Е.В., др. Клинические рекомендации по диагностике и лечению хронической тромбоэмболической легочной гипертензии. (2 ЧАСТЬ). Терапевтический архив 2016; 88 (10): 63-74. DOI: 10.17116/terarkh201688663-73</mixed-citation><mixed-citation xml:lang="en">Чазова И.Е., Мартынюк Т.В., Филиппов Е.В., др. Клинические рекомендации по диагностике и лечению хронической тромбоэмболической легочной гипертензии. (2 ЧАСТЬ). Терапевтический архив 2016; 88 (10): 63-74. DOI: 10.17116/terarkh201688663-73</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Чазова И.Е., Мартынюк Т.В., Валиева З.С., др. Оценка бремени хронической тромбоэмболической легочной гипертензии в Российской Федерации. Терапевтический архив 2018; 90 (9): 101-109. DOI: 10.26442/terarkh2018909101-109</mixed-citation><mixed-citation xml:lang="en">Чазова И.Е., Мартынюк Т.В., Валиева З.С., др. Оценка бремени хронической тромбоэмболической легочной гипертензии в Российской Федерации. Терапевтический архив 2018; 90 (9): 101-109. DOI: 10.26442/terarkh2018909101-109</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Чазова И.Е., Валиева З.С, Наконечников С.Н., др. Особенности клинико-функционального и гемодинамического профиля, лекарственной терапии и оценка прогноза у пациентов с: неоперабельной хронической тромбоэмболической и: идиопатической легочной гипертензией по данным Российского регистра. Терапевтический архив 2019; 88 (10): 77-87. DOI: 10.26442/00403660.2019.09.000343</mixed-citation><mixed-citation xml:lang="en">Чазова И.Е., Валиева З.С, Наконечников С.Н., др. Особенности клинико-функционального и гемодинамического профиля, лекарственной терапии и оценка прогноза у пациентов с: неоперабельной хронической тромбоэмболической и: идиопатической легочной гипертензией по данным Российского регистра. Терапевтический архив 2019; 88 (10): 77-87. DOI: 10.26442/00403660.2019.09.000343</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Чазова И.Е., Мартынюк Т.В., Валиева З.С., др. Евразийские клинические рекомендации по диагностике и лечению легочной гипертензии. Евразийский кардиологический журнал 2020; 1: 78-122. DOI: 10.38109/2225-1685-2020-1-78-122</mixed-citation><mixed-citation xml:lang="en">Чазова И.Е., Мартынюк Т.В., Валиева З.С., др. Евразийские клинические рекомендации по диагностике и лечению легочной гипертензии. Евразийский кардиологический журнал 2020; 1: 78-122. DOI: 10.38109/2225-1685-2020-1-78-122</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Чернявский А. М., Едемский А. Г., Новикова Н. В., др. Применение радиочастотной абляции легочной артерии при лечении резидуальной легочной гипертензии после легочной эндартерэктомии. Кардиология 2018; 58 (4):15-21. https://doi.org/10.18087/cardio.2018.4.10105</mixed-citation><mixed-citation xml:lang="en">Чернявский А. М., Едемский А. Г., Новикова Н. В., др. Применение радиочастотной абляции легочной артерии при лечении резидуальной легочной гипертензии после легочной эндартерэктомии. Кардиология 2018; 58 (4):15-21. https://doi.org/10.18087/cardio.2018.4.10105</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Чернявский А.М., Едемский А.Г., Чернявский М.А., Караськов А.М. Глава «Хроническая тромбоэмболическая легочная гипертензия»/ Руководство «Легочная гипертензия». 2-е издание под редакцией С.Н. Авдеева. —М.: ГЭОТАР-Медиа 2019. —С. 365-418.</mixed-citation><mixed-citation xml:lang="en">Чернявский А.М., Едемский А.Г., Чернявский М.А., Караськов А.М. Глава «Хроническая тромбоэмболическая легочная гипертензия»/ Руководство «Легочная гипертензия». 2-е издание под редакцией С.Н. Авдеева. —М.: ГЭОТАР-Медиа 2019. —С. 365-418.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Хирургическое лечение хронической тромбоэмболической легочной гипертензии / А.М. Чернявский, А.Г. Едемский, Н.В. Новикова и др.; под общ. ред. А.М. Чернявского; ФГБУ «НМИЦ им. ак. Е.Н. Мешалкина» Минздрава России. - Новосибирск: Изд-во СО РАН, 2019. - 318 с.</mixed-citation><mixed-citation xml:lang="en">Хирургическое лечение хронической тромбоэмболической легочной гипертензии / А.М. Чернявский, А.Г. Едемский, Н.В. Новикова и др.; под общ. ред. А.М. Чернявского; ФГБУ «НМИЦ им. ак. Е.Н. Мешалкина» Минздрава России. - Новосибирск: Изд-во СО РАН, 2019. - 318 с.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Шмальц А.А., Горбачевский С.В. Риоцигуат и силденафил в лечении легочной гипертензии: сходства и различия. Пульмонология 2016; 26 (1): 85-91. https://doi.org/10.18093/0869-0189-2016-26-1-85-91</mixed-citation><mixed-citation xml:lang="en">Шмальц А.А., Горбачевский С.В. Риоцигуат и силденафил в лечении легочной гипертензии: сходства и различия. Пульмонология 2016; 26 (1): 85-91. https://doi.org/10.18093/0869-0189-2016-26-1-85-91</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Adams A, Fedullo PF. Postoperative management of the patient undergoing pulmonary endarterectomy. Semin Thorac Cardiovasc Surg. 2006; 18(3): 250-256. DOI: 10.1053/j.semtcvs.2006.09.002</mixed-citation><mixed-citation xml:lang="en">Adams A, Fedullo PF. Postoperative management of the patient undergoing pulmonary endarterectomy. Semin Thorac Cardiovasc Surg. 2006; 18(3): 250-256. DOI: 10.1053/j.semtcvs.2006.09.002</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Auger W.R., Moser K.M. Pulmonary flow murmurs: a distinctive physical sign found in chronic pulmonary thromboembolic disease, Clin. Res. 1989; 37:145A. doi.org/10.1148/radiology.182.2.1732955</mixed-citation><mixed-citation xml:lang="en">Auger W.R., Moser K.M. Pulmonary flow murmurs: a distinctive physical sign found in chronic pulmonary thromboembolic disease, Clin. Res. 1989; 37:145A. doi.org/10.1148/radiology.182.2.1732955</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Becattini C., Manina G., Busti C., et al. Bosentan for chronic thromboembolic pulmonary hypertension: findings from a systematic review and meta-analysis. Thromb Res 2010; 126 (1): e51–e56. DOI: 10.1016/j.thromres.2010.01.007</mixed-citation><mixed-citation xml:lang="en">Becattini C., Manina G., Busti C., et al. Bosentan for chronic thromboembolic pulmonary hypertension: findings from a systematic review and meta-analysis. Thromb Res 2010; 126 (1): e51–e56. DOI: 10.1016/j.thromres.2010.01.007</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Benson D.G, Schiebler M.L, Repplinger M.D., et al. Contrast-enhanced pulmonary MRA for the primary diagnosis of pulmonary embolism: current state of the art and future directions. Br J Radiol 2017; 90 (1074): 553-563. doi: 10.1259/bjr.20160901</mixed-citation><mixed-citation xml:lang="en">Benson D.G, Schiebler M.L, Repplinger M.D., et al. Contrast-enhanced pulmonary MRA for the primary diagnosis of pulmonary embolism: current state of the art and future directions. Br J Radiol 2017; 90 (1074): 553-563. doi: 10.1259/bjr.20160901</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Bergin C.J., Sirlin S., Hauschildt J., et al. Chronic thromboembolism: diagnosis with helical CT and MR imaging with angiographic and surgical correlation. Radiology 1997;204: 695–702. doi.org/10.1148/radiology.204.3.9280245</mixed-citation><mixed-citation xml:lang="en">Bergin C.J., Sirlin S., Hauschildt J., et al. Chronic thromboembolism: diagnosis with helical CT and MR imaging with angiographic and surgical correlation. Radiology 1997;204: 695–702. doi.org/10.1148/radiology.204.3.9280245</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Cannon J.E, Su L., Kiely D.G., et al. Dynamic risk stratification of patient long-term outcome after pulmonary endarterectomy: results from the United Kingdom national cohort. Circulation 2016; 133: 1761–1771. DOI: 10.1161/CIRCULATIONAHA.115.019470</mixed-citation><mixed-citation xml:lang="en">Cannon J.E, Su L., Kiely D.G., et al. Dynamic risk stratification of patient long-term outcome after pulmonary endarterectomy: results from the United Kingdom national cohort. Circulation 2016; 133: 1761–1771. DOI: 10.1161/CIRCULATIONAHA.115.019470</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Ciurzynski M., Kurzyna M., Bochowicz A., et al. Long-term effects of acute pulmonary embolism on echocardiographic Doppler indices and functional capacity. Clin Cardiol 2004; Vol. 27: 693–697. DOI: 10.1002/clc.4960271207</mixed-citation><mixed-citation xml:lang="en">Ciurzynski M., Kurzyna M., Bochowicz A., et al. Long-term effects of acute pulmonary embolism on echocardiographic Doppler indices and functional capacity. Clin Cardiol 2004; Vol. 27: 693–697. DOI: 10.1002/clc.4960271207</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Condliffe R, Kiely DG, Gibbs JS, Corris PA, Peacock AJ, Jenkins DP, et al. Prognostic and aetiological factors in chronic thromboembolic pulmonary hypertension. Eur Respir J. 2009; 33: 332-8. DOI: 10.1183/09031936.00092008</mixed-citation><mixed-citation xml:lang="en">Condliffe R, Kiely DG, Gibbs JS, Corris PA, Peacock AJ, Jenkins DP, et al. Prognostic and aetiological factors in chronic thromboembolic pulmonary hypertension. Eur Respir J. 2009; 33: 332-8. DOI: 10.1183/09031936.00092008</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Corris P.A. National audit of pulmonary hypertension 2012. Leeds, UK: Health and Social Care Information Centre; 2013 [accessed 2016 May 9]. Available from: http://www.hscic.gov.uk/catalogue/PUB10535/nati-pulmhype-audi-2012-rep.pdf</mixed-citation><mixed-citation xml:lang="en">Corris P.A. National audit of pulmonary hypertension 2012. Leeds, UK: Health and Social Care Information Centre; 2013 [accessed 2016 May 9]. Available from: http://www.hscic.gov.uk/catalogue/PUB10535/nati-pulmhype-audi-2012-rep.pdf</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Chazova I., Martynyuk T., Valieva Z., et al. Clinical and instrumental characteristics of newly diagnosed patients with various forms of pulmonary hypertension according to the Russian National Registry. Biomed Res Int. 2020 Jun 14;2020:6836973. doi: 10.1155/2020/6836973.</mixed-citation><mixed-citation xml:lang="en">Chazova I., Martynyuk T., Valieva Z., et al. Clinical and instrumental characteristics of newly diagnosed patients with various forms of pulmonary hypertension according to the Russian National Registry. Biomed Res Int. 2020 Jun 14;2020:6836973. doi: 10.1155/2020/6836973.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Cohn J.N. Optimal diuretic therapy for heart failure. Am J Med 2001; 111: 577. DOI: 10.1016/s0002-9343(01)00915-9</mixed-citation><mixed-citation xml:lang="en">Cohn J.N. Optimal diuretic therapy for heart failure. Am J Med 2001; 111: 577. DOI: 10.1016/s0002-9343(01)00915-9</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">D’Armini A.M., Morsolini M., Mattiucci G., et al. Pulmonary endarterectomy for distal chronic thromboembolic pulmonary hypertension. J Thorac Cardiovasc Surg 2014; 148: 1005–1011. doi.org/10.1016/j.jtcvs.2014.06.052</mixed-citation><mixed-citation xml:lang="en">D’Armini A.M., Morsolini M., Mattiucci G., et al. Pulmonary endarterectomy for distal chronic thromboembolic pulmonary hypertension. J Thorac Cardiovasc Surg 2014; 148: 1005–1011. doi.org/10.1016/j.jtcvs.2014.06.052</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Darocha S., Banaszkiewicz M., Pietrasik A., et al. Sequential treatment with sildenafil and riociguat in patients with persistent or inoperable chronic thromboembolic pulmonary hypertension improves functional class and pulmonary hemodynamics. Int J Cardiol. 2018; 269: 283-288. DOI: 10.1016/j.ijcard.2018.07.015</mixed-citation><mixed-citation xml:lang="en">Darocha S., Banaszkiewicz M., Pietrasik A., et al. Sequential treatment with sildenafil and riociguat in patients with persistent or inoperable chronic thromboembolic pulmonary hypertension improves functional class and pulmonary hemodynamics. Int J Cardiol. 2018; 269: 283-288. DOI: 10.1016/j.ijcard.2018.07.015</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Delcroix M., Lang I., Pepke-Zaba J., et al. Long-term outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. Circulation 2016; 133: 859–71. doi: 10.1161/CIRCULATIONAHA.115.016522</mixed-citation><mixed-citation xml:lang="en">Delcroix M., Lang I., Pepke-Zaba J., et al. Long-term outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. Circulation 2016; 133: 859–71. doi: 10.1161/CIRCULATIONAHA.115.016522</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Escribano-Subias P., Blanco I., López-Meseguer M., et al. Survival in pulmonary hypertension in Spain: insights from the Spanish registry. Eur. Respi.J. 2012. —Vol. 40 (3).—P.596-603. DOI: 10.1183/09031936.00101211</mixed-citation><mixed-citation xml:lang="en">Escribano-Subias P., Blanco I., López-Meseguer M., et al. Survival in pulmonary hypertension in Spain: insights from the Spanish registry. Eur. Respi.J. 2012. —Vol. 40 (3).—P.596-603. DOI: 10.1183/09031936.00101211</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Fedullo P.F., Auger W.R., Kerr K.M., Rubin L.J. Chronic thromboembolic pulmonary hypertension. N Engl J Med 2001; 345:1465-1472. DOI: 10.1056/NEJMra010902</mixed-citation><mixed-citation xml:lang="en">Fedullo P.F., Auger W.R., Kerr K.M., Rubin L.J. Chronic thromboembolic pulmonary hypertension. N Engl J Med 2001; 345:1465-1472. DOI: 10.1056/NEJMra010902</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Fisher M.R., Forfia P.R., Chamera E., et al. Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Resp Crit Care Med 2009; 179: 615-621. DOI: 10.1164/rccm.200811-1691OC</mixed-citation><mixed-citation xml:lang="en">Fisher M.R., Forfia P.R., Chamera E., et al. Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Resp Crit Care Med 2009; 179: 615-621. DOI: 10.1164/rccm.200811-1691OC</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Fukuda K., Hiroshi Date H., Doi S., et al. Guidelines for the Treatment of Pulmonary Hypertension (JCS 2017/JPCPHS 2017). Circ J 2019; 83 (4): 842-945. DOI: 10.1253/circj.CJ-66-0158</mixed-citation><mixed-citation xml:lang="en">Fukuda K., Hiroshi Date H., Doi S., et al. Guidelines for the Treatment of Pulmonary Hypertension (JCS 2017/JPCPHS 2017). Circ J 2019; 83 (4): 842-945. DOI: 10.1253/circj.CJ-66-0158</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Fukui S., Ogo T., Morita Y., et al. Right ventricular reverse remodelling after balloon pulmonary angioplasty. Eur Respir J 2014; 43:1394–1402. DOI: 10.1183/09031936.00012914</mixed-citation><mixed-citation xml:lang="en">Fukui S., Ogo T., Morita Y., et al. Right ventricular reverse remodelling after balloon pulmonary angioplasty. Eur Respir J 2014; 43:1394–1402. DOI: 10.1183/09031936.00012914</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Galie N., Humbert M., Vachiery J.L, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Eur Respir J. 2015; 46(4):903-75. DOI: 10.1183/13993003.01032-2015</mixed-citation><mixed-citation xml:lang="en">Galie N., Humbert M., Vachiery J.L, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Eur Respir J. 2015; 46(4):903-75. DOI: 10.1183/13993003.01032-2015</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Gall H., Vachiéry J.L., Tanabe N. et al. Real-World Switching to Riociguat: Management and Practicalities in Patients with PAH and CTEPH. Lung 2018; 196: 305–312. DOI: 10.1007/s00408-018-0100-3</mixed-citation><mixed-citation xml:lang="en">Gall H., Vachiéry J.L., Tanabe N. et al. Real-World Switching to Riociguat: Management and Practicalities in Patients with PAH and CTEPH. Lung 2018; 196: 305–312. DOI: 10.1007/s00408-018-0100-3</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Ghofrani HA, Schermuly RT, Rose F., et al. Sildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 2003; 167: 1139–1141. DOI: 10.1164/rccm.200210-1157BC</mixed-citation><mixed-citation xml:lang="en">Ghofrani HA, Schermuly RT, Rose F., et al. Sildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 2003; 167: 1139–1141. DOI: 10.1164/rccm.200210-1157BC</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Ghofrani H.A., Hoeper M.M., Halank M., et al. Riociguat for chronic Thromboembolic pulmonary hypertension and pulmonary arterial hypertension: A phase II study. Eur Respir J 2010; Vol. 36: 792–799. DOI: 10.1183/09031936.00182909</mixed-citation><mixed-citation xml:lang="en">Ghofrani H.A., Hoeper M.M., Halank M., et al. Riociguat for chronic Thromboembolic pulmonary hypertension and pulmonary arterial hypertension: A phase II study. Eur Respir J 2010; Vol. 36: 792–799. DOI: 10.1183/09031936.00182909</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Ghofrani H.A., D’Armini A.M., Grimminger F., et al. CHEST-1 Study Group. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med. 2013; 369 (4): 319-329. DOI: 10.1056/NEJMoa1209657</mixed-citation><mixed-citation xml:lang="en">Ghofrani H.A., D’Armini A.M., Grimminger F., et al. CHEST-1 Study Group. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med. 2013; 369 (4): 319-329. DOI: 10.1056/NEJMoa1209657</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Ghofrani H.A., Simonneau G., D’Armini A.M., Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebocontrolled study./ Lancet. Respir. Med. — 2017. — Vol. 5 (10). — Р.785-794. DOI: 10.1016/S2213-2600(17)30305-3</mixed-citation><mixed-citation xml:lang="en">Ghofrani H.A., Simonneau G., D’Armini A.M., Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebocontrolled study./ Lancet. Respir. Med. — 2017. — Vol. 5 (10). — Р.785-794. DOI: 10.1016/S2213-2600(17)30305-3</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Gopalan D., Delcroix M., Held M. Diagnosis of chronic thromboembolic pulmonary hypertension. Eur Respir Review 2017; 26: 160108. DOI: 10.1183/16000617.0108-2016</mixed-citation><mixed-citation xml:lang="en">Gopalan D., Delcroix M., Held M. Diagnosis of chronic thromboembolic pulmonary hypertension. Eur Respir Review 2017; 26: 160108. DOI: 10.1183/16000617.0108-2016</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Grondelle A., Ditchey R.V., Groves B.M., et al. Thermodilution method overestimates low cardiac output in humans. Am J Physiol 1983. 245: H690–H692. DOI: 10.1152/ajpheart.1983.245.4.H690</mixed-citation><mixed-citation xml:lang="en">Grondelle A., Ditchey R.V., Groves B.M., et al. Thermodilution method overestimates low cardiac output in humans. Am J Physiol 1983. 245: H690–H692. DOI: 10.1152/ajpheart.1983.245.4.H690</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Guerin L., Couturaud F., Parent F., et al. Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Thromb Haemost 2014; 112: 598–605. DOI: 10.1160/TH13-07-0538</mixed-citation><mixed-citation xml:lang="en">Guerin L., Couturaud F., Parent F., et al. Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Thromb Haemost 2014; 112: 598–605. DOI: 10.1160/TH13-07-0538</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Guth S., Wiedenroth C.B., Wellenschlages M., et al. Short-term venoarterial extracorporeal membrane oxygenation for massive endobronchial hemorrhage after pulmonary endarterectomy. J Thorac Cardiovasc Surg 2018;155:643-9. DOI: 10.1016/j.jtcvs.2017.09.045</mixed-citation><mixed-citation xml:lang="en">Guth S., Wiedenroth C.B., Wellenschlages M., et al. Short-term venoarterial extracorporeal membrane oxygenation for massive endobronchial hemorrhage after pulmonary endarterectomy. J Thorac Cardiovasc Surg 2018;155:643-9. DOI: 10.1016/j.jtcvs.2017.09.045</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Hoeper M.M., Mayer E., Simonneau G. et al. Chronic thromboembolic pulmonary hypertension. Circulation 2006; 113: 2011–2020. doi.org/10.1161/CIRCULATIONAHA.105.602565</mixed-citation><mixed-citation xml:lang="en">Hoeper M.M., Mayer E., Simonneau G. et al. Chronic thromboembolic pulmonary hypertension. Circulation 2006; 113: 2011–2020. doi.org/10.1161/CIRCULATIONAHA.105.602565</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Hoeper M.M., Ghofrani H.A., Al-Hiti H., et al. Switching from phosphodiesterase type 5 inhibitors to riociguat in patients with pulmonary arterial hypertension: The REPLACE study. E-POSTER (Nr 3802) presented on the ERS 2020 International Conference Virtual Platform. Available at: https://ers.conference2web.com/#!resources/late-breaking-abstractswitching-from-pde5i-to-riociguat-in-patients-with-pah-the-replacestudy-158fd49b-b44a-495f-929d-3d5212141655.</mixed-citation><mixed-citation xml:lang="en">Hoeper M.M., Ghofrani H.A., Al-Hiti H., et al. Switching from phosphodiesterase type 5 inhibitors to riociguat in patients with pulmonary arterial hypertension: The REPLACE study. E-POSTER (Nr 3802) presented on the ERS 2020 International Conference Virtual Platform. Available at: https://ers.conference2web.com/#!resources/late-breaking-abstractswitching-from-pde5i-to-riociguat-in-patients-with-pah-the-replacestudy-158fd49b-b44a-495f-929d-3d5212141655.</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Jais X., D’Armini A.M., Jansa P., et al. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects ininoperable forms of chronic thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial./ J. Am. Coll. Cardiol. —2008. —Vol. 52. —Р.2127–2134. doi: 10.1016/j.jacc.2008.08.059.</mixed-citation><mixed-citation xml:lang="en">Jais X., D’Armini A.M., Jansa P., et al. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects ininoperable forms of chronic thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial./ J. Am. Coll. Cardiol. —2008. —Vol. 52. —Р.2127–2134. doi: 10.1016/j.jacc.2008.08.059.</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Jais X, Brenot P, Bouvaist H, et al. Late Breaking Abstract - Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension: results from the randomised controlled RACE study. Eur Respir J. 2019; 54:RCT1885. DOI: 10.1183/13993003.congress-2019.RCT1885</mixed-citation><mixed-citation xml:lang="en">Jais X, Brenot P, Bouvaist H, et al. Late Breaking Abstract - Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension: results from the randomised controlled RACE study. Eur Respir J. 2019; 54:RCT1885. DOI: 10.1183/13993003.congress-2019.RCT1885</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Jamieson SW, Kapelanski DP, Sakakibara N, et al. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg. 2003;76:1457–1464. DOI: 10.1016/s0003-4975(03)00828-2</mixed-citation><mixed-citation xml:lang="en">Jamieson SW, Kapelanski DP, Sakakibara N, et al. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg. 2003;76:1457–1464. DOI: 10.1016/s0003-4975(03)00828-2</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Jenkins D., Mayer E., Screaton N., Madani M. State-of-the-art chronic thromboembolic pulmonary hypertension: diagnosis and management. Eur Respir Rev 2012;21:32–39. DOI: 10.1183/09059180.00009211</mixed-citation><mixed-citation xml:lang="en">Jenkins D., Mayer E., Screaton N., Madani M. State-of-the-art chronic thromboembolic pulmonary hypertension: diagnosis and management. Eur Respir Rev 2012;21:32–39. DOI: 10.1183/09059180.00009211</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Jensen K.W., Kerr K.M., Fedullo P.F., et al. Pulmonary hypertensive medical therapy in chronic thromboembolic pulmonary hypertension before pulmonary thromboendarterectomy. Circulation 2009; 120: 1248–1254. DOI: 10.1161/CIRCULATIONAHA.109.865881</mixed-citation><mixed-citation xml:lang="en">Jensen K.W., Kerr K.M., Fedullo P.F., et al. Pulmonary hypertensive medical therapy in chronic thromboembolic pulmonary hypertension before pulmonary thromboendarterectomy. Circulation 2009; 120: 1248–1254. DOI: 10.1161/CIRCULATIONAHA.109.865881</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Kataoka M., Inami T., Hayashida K., et al. Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv 2012; 5: 756 – 762. DOI: 10.1161/CIRCINTERVENTIONS.112.971390</mixed-citation><mixed-citation xml:lang="en">Kataoka M., Inami T., Hayashida K., et al. Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv 2012; 5: 756 – 762. DOI: 10.1161/CIRCINTERVENTIONS.112.971390</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Kim N.H., Delcroix M., Jais X. et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J 2019; 53: 1801915. DOI: 10.1183/13993003.01915-2018</mixed-citation><mixed-citation xml:lang="en">Kim N.H., Delcroix M., Jais X. et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J 2019; 53: 1801915. DOI: 10.1183/13993003.01915-2018</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Konstantinides C.V., Torbick A., Giancarlo Agnelli G, et al. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2014; 35: 3033–3080. DOI: 10.1093/eurheartj/ehn310</mixed-citation><mixed-citation xml:lang="en">Konstantinides C.V., Torbick A., Giancarlo Agnelli G, et al. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2014; 35: 3033–3080. DOI: 10.1093/eurheartj/ehn310</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Korsholm K., Andersen A., Mellemkjær S., et al. Results from more than 20 years of surgical pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension in Denmark. EurJ Cardiothorac Surg, 2017; 52(4):704-709. doi.org/10.1093/ejcts/ezx182</mixed-citation><mixed-citation xml:lang="en">Korsholm K., Andersen A., Mellemkjær S., et al. Results from more than 20 years of surgical pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension in Denmark. EurJ Cardiothorac Surg, 2017; 52(4):704-709. doi.org/10.1093/ejcts/ezx182</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Kovacs G., Avian A., Pienn M., et al. Reading pulmonary vascular pressure tracings. How to handle the problems of zero leveling and respiratory swings? Am J Respir Crit Care Med 2014; 190: 252–257. DOI: 10.1164/rccm.201402-0269PP</mixed-citation><mixed-citation xml:lang="en">Kovacs G., Avian A., Pienn M., et al. Reading pulmonary vascular pressure tracings. How to handle the problems of zero leveling and respiratory swings? Am J Respir Crit Care Med 2014; 190: 252–257. DOI: 10.1164/rccm.201402-0269PP</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Kramm T. et al. Incidence and characteristics of chronic thromboembolic pulmonary hypertension in Germany. Clin Research in Cardiol 2018; 107 (6): 548-553. DOI: 10.1007/s00392-018-1215-5</mixed-citation><mixed-citation xml:lang="en">Kramm T. et al. Incidence and characteristics of chronic thromboembolic pulmonary hypertension in Germany. Clin Research in Cardiol 2018; 107 (6): 548-553. DOI: 10.1007/s00392-018-1215-5</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Kramm T. et al. Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy. Eur J of Cardio-thoracic surgery 2005; 28 (6): 882-888. DOI: 10.1016/j.ejcts.2005.09.007</mixed-citation><mixed-citation xml:lang="en">Kramm T. et al. Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy. Eur J of Cardio-thoracic surgery 2005; 28 (6): 882-888. DOI: 10.1016/j.ejcts.2005.09.007</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">Lang I.M., Plank C., Sadushi-Kolici R., et al. Imaging in pulmonary hypertension. JACC Cardiovasc Imaging 2010; 3: 1287–1295. doi.org/10.1016/j.jcmg.2010.09.013</mixed-citation><mixed-citation xml:lang="en">Lang I.M., Plank C., Sadushi-Kolici R., et al. Imaging in pulmonary hypertension. JACC Cardiovasc Imaging 2010; 3: 1287–1295. doi.org/10.1016/j.jcmg.2010.09.013</mixed-citation></citation-alternatives></ref><ref id="cit73"><label>73</label><citation-alternatives><mixed-citation xml:lang="ru">Lang I., Simonneau G., Pepke-Zaba J., et al. Factors associated with diagnosis and operability of chronic thromboembolic pulmonary hypertension: a case-control study. Thromb Haemost 2013; 110: 83–91. DOI: 10.1160/TH13-02-0097</mixed-citation><mixed-citation xml:lang="en">Lang I., Simonneau G., Pepke-Zaba J., et al. Factors associated with diagnosis and operability of chronic thromboembolic pulmonary hypertension: a case-control study. Thromb Haemost 2013; 110: 83–91. DOI: 10.1160/TH13-02-0097</mixed-citation></citation-alternatives></ref><ref id="cit74"><label>74</label><citation-alternatives><mixed-citation xml:lang="ru">Ley S., Ley-Zaporozhan J., Pitton M.B., et al. Diagnostic performance of state-of-the-art imaging techniques for morphological assessment of vascular abnormalities in patients with chronic thromboembolic pulmonary hypertension (CTEPH). Eur Radiol 2012;22: 607–616. DOI: 10.1007/s00330-011-2290-4</mixed-citation><mixed-citation xml:lang="en">Ley S., Ley-Zaporozhan J., Pitton M.B., et al. Diagnostic performance of state-of-the-art imaging techniques for morphological assessment of vascular abnormalities in patients with chronic thromboembolic pulmonary hypertension (CTEPH). Eur Radiol 2012;22: 607–616. DOI: 10.1007/s00330-011-2290-4</mixed-citation></citation-alternatives></ref><ref id="cit75"><label>75</label><citation-alternatives><mixed-citation xml:lang="ru">Madani MM, Auger WR, Pretorius V, et al. Pulmonary endarterectomy: recent changes in a single institution’s experience of more than 2,700 patients. Ann Thorac Surg 2012; 94: 97–103. DOI: 10.1016/j.athoracsur.2012.04.004</mixed-citation><mixed-citation xml:lang="en">Madani MM, Auger WR, Pretorius V, et al. Pulmonary endarterectomy: recent changes in a single institution’s experience of more than 2,700 patients. Ann Thorac Surg 2012; 94: 97–103. DOI: 10.1016/j.athoracsur.2012.04.004</mixed-citation></citation-alternatives></ref><ref id="cit76"><label>76</label><citation-alternatives><mixed-citation xml:lang="ru">Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ. Delayed enhancement cardiovascular magnetic resonance assessment of nonischaemic cardiomyopathies. Eur Heart J 2005; 26 (15): 1461–1474. DOI:10.1093/eurheartj/ehi258</mixed-citation><mixed-citation xml:lang="en">Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ. Delayed enhancement cardiovascular magnetic resonance assessment of nonischaemic cardiomyopathies. Eur Heart J 2005; 26 (15): 1461–1474. DOI:10.1093/eurheartj/ehi258</mixed-citation></citation-alternatives></ref><ref id="cit77"><label>77</label><citation-alternatives><mixed-citation xml:lang="ru">Mehta S., Helmersen D., Provencher S., et al. Diagnostic evaluation and management of chronic thromboembolic pulmonary hypertension: a clinical practice guideline. Can Respir J. 2010; 17(6):301-34. DOI: 10.1155/2010/704258</mixed-citation><mixed-citation xml:lang="en">Mehta S., Helmersen D., Provencher S., et al. Diagnostic evaluation and management of chronic thromboembolic pulmonary hypertension: a clinical practice guideline. Can Respir J. 2010; 17(6):301-34. DOI: 10.1155/2010/704258</mixed-citation></citation-alternatives></ref><ref id="cit78"><label>78</label><citation-alternatives><mixed-citation xml:lang="ru">McGoon M., Gutterman D., Steen V., et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence based clinical practice guidelines. Chest 2004; 126: 14S–34S. DOI: 10.1378/chest.126.1_suppl.14S</mixed-citation><mixed-citation xml:lang="en">McGoon M., Gutterman D., Steen V., et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence based clinical practice guidelines. Chest 2004; 126: 14S–34S. DOI: 10.1378/chest.126.1_suppl.14S</mixed-citation></citation-alternatives></ref><ref id="cit79"><label>79</label><citation-alternatives><mixed-citation xml:lang="ru">Mueller-Mottet S., Stricker H., Domenighetti G et al. Long-term data from the Swiss pulmonary hypertension registry. Respiration 2015; 89:127–140. DOI: 10.1159/000370125</mixed-citation><mixed-citation xml:lang="en">Mueller-Mottet S., Stricker H., Domenighetti G et al. Long-term data from the Swiss pulmonary hypertension registry. Respiration 2015; 89:127–140. DOI: 10.1159/000370125</mixed-citation></citation-alternatives></ref><ref id="cit80"><label>80</label><citation-alternatives><mixed-citation xml:lang="ru">Mayer E, Jenkins D, Lindner J, et al. Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J Thorac Cardiovasc Surg 2011; 141: 702–10. DOI: 10.1016/j.jtcvs.2010.11.024</mixed-citation><mixed-citation xml:lang="en">Mayer E, Jenkins D, Lindner J, et al. Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J Thorac Cardiovasc Surg 2011; 141: 702–10. DOI: 10.1016/j.jtcvs.2010.11.024</mixed-citation></citation-alternatives></ref><ref id="cit81"><label>81</label><citation-alternatives><mixed-citation xml:lang="ru">Neder J.A., Ramos R.P., Ota-Arakaki J.S., et al. Exercise intolerance in pulmonary arterial hypertension. The role of cardiopulmonary exercise testing. Ann Am Thorac Soc 2015; 12: 604–612. DOI: 10.1513/AnnalsATS.201412-558CC</mixed-citation><mixed-citation xml:lang="en">Neder J.A., Ramos R.P., Ota-Arakaki J.S., et al. Exercise intolerance in pulmonary arterial hypertension. The role of cardiopulmonary exercise testing. Ann Am Thorac Soc 2015; 12: 604–612. DOI: 10.1513/AnnalsATS.201412-558CC</mixed-citation></citation-alternatives></ref><ref id="cit82"><label>82</label><citation-alternatives><mixed-citation xml:lang="ru">Nishikawa T., Dohi S. Errors in the measurement of cardiac output by thermodilution. Can J Anaesth 1993; 40:142–153. DOI: 10.1007/BF03011312</mixed-citation><mixed-citation xml:lang="en">Nishikawa T., Dohi S. Errors in the measurement of cardiac output by thermodilution. Can J Anaesth 1993; 40:142–153. DOI: 10.1007/BF03011312</mixed-citation></citation-alternatives></ref><ref id="cit83"><label>83</label><citation-alternatives><mixed-citation xml:lang="ru">Olschewski H., Simonneau G., Galie N., et al. for the AIR Study Group. Inhaled iloprost in severe pulmonary hypertension. N Engl J Med 2002; 347:322-329. DOI: 10.1056/NEJMoa020204</mixed-citation><mixed-citation xml:lang="en">Olschewski H., Simonneau G., Galie N., et al. for the AIR Study Group. Inhaled iloprost in severe pulmonary hypertension. N Engl J Med 2002; 347:322-329. DOI: 10.1056/NEJMoa020204</mixed-citation></citation-alternatives></ref><ref id="cit84"><label>84</label><citation-alternatives><mixed-citation xml:lang="ru">Pengo V., Lensing A.W., Prins M.H., et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004;350: 2257–2264. DOI: 10.1056/NEJMoa032274</mixed-citation><mixed-citation xml:lang="en">Pengo V., Lensing A.W., Prins M.H., et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004;350: 2257–2264. DOI: 10.1056/NEJMoa032274</mixed-citation></citation-alternatives></ref><ref id="cit85"><label>85</label><citation-alternatives><mixed-citation xml:lang="ru">Pepke-Zaba J., Delcroix M., Lang I., et al. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation 2011;124:1973–1981. doi.org/10.1161/CIRCULATIONAHA.110.015008</mixed-citation><mixed-citation xml:lang="en">Pepke-Zaba J., Delcroix M., Lang I., et al. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation 2011;124:1973–1981. doi.org/10.1161/CIRCULATIONAHA.110.015008</mixed-citation></citation-alternatives></ref><ref id="cit86"><label>86</label><citation-alternatives><mixed-citation xml:lang="ru">Pepke-Zaba J., Hoeper M.M., Humbert M. Chronic thromboembolic pulmonary hypertension: advances from bench to patient management. Eur Respir J 2013; 41: 8–9. DOI: 10.1183/09031936.00181212</mixed-citation><mixed-citation xml:lang="en">Pepke-Zaba J., Hoeper M.M., Humbert M. Chronic thromboembolic pulmonary hypertension: advances from bench to patient management. Eur Respir J 2013; 41: 8–9. DOI: 10.1183/09031936.00181212</mixed-citation></citation-alternatives></ref><ref id="cit87"><label>87</label><citation-alternatives><mixed-citation xml:lang="ru">Pretorius V, Alayadhi W, Modry D. Extracorporeal life support for the control of life-threatening pulmonary hemorrhage. Ann Thorac Surg. 2009;88:649–50. DOI: 10.1016/j.athoracsur.2008.12.066</mixed-citation><mixed-citation xml:lang="en">Pretorius V, Alayadhi W, Modry D. Extracorporeal life support for the control of life-threatening pulmonary hemorrhage. Ann Thorac Surg. 2009;88:649–50. DOI: 10.1016/j.athoracsur.2008.12.066</mixed-citation></citation-alternatives></ref><ref id="cit88"><label>88</label><citation-alternatives><mixed-citation xml:lang="ru">Pulido T., Adzerikho I., Channick R.N., et al. Macitentan and morbidity and mortality in pulmonary arterial hypertension. N Engl J Med 2013; 369: 809–818. DOI: 10.1056/NEJMoa1213917</mixed-citation><mixed-citation xml:lang="en">Pulido T., Adzerikho I., Channick R.N., et al. Macitentan and morbidity and mortality in pulmonary arterial hypertension. N Engl J Med 2013; 369: 809–818. DOI: 10.1056/NEJMoa1213917</mixed-citation></citation-alternatives></ref><ref id="cit89"><label>89</label><citation-alternatives><mixed-citation xml:lang="ru">Reichenberger F., Voswinckel R., Enke B., et al. Long-term treatment with sildenafil in chronic thromboembolic pulmonary hypertension. Eur Respir J 2007. 30: 922–927.DOI: 10.1183/09031936.00039007</mixed-citation><mixed-citation xml:lang="en">Reichenberger F., Voswinckel R., Enke B., et al. Long-term treatment with sildenafil in chronic thromboembolic pulmonary hypertension. Eur Respir J 2007. 30: 922–927.DOI: 10.1183/09031936.00039007</mixed-citation></citation-alternatives></ref><ref id="cit90"><label>90</label><citation-alternatives><mixed-citation xml:lang="ru">Reesink H.J., van der Plas M.N., Verhey N.E., et al. Six-minute walk distance as parameter of functional outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. J Thorac Cardiovasc Surg 2007; 133: 510–516. DOI: 10.1016/j.jtcvs.2006.10.020</mixed-citation><mixed-citation xml:lang="en">Reesink H.J., van der Plas M.N., Verhey N.E., et al. Six-minute walk distance as parameter of functional outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. J Thorac Cardiovasc Surg 2007; 133: 510–516. DOI: 10.1016/j.jtcvs.2006.10.020</mixed-citation></citation-alternatives></ref><ref id="cit91"><label>91</label><citation-alternatives><mixed-citation xml:lang="ru">Romanov A., Cherniavskiy A., Novikova N., et al. Pulmonary Artery Denervation for Patients With Residual Pulmonary Hypertension After Pulmonary Endarterectomy. JACC 2020; 76 (8): 916-26. DOI: 10.1016/j.jacc.2020.06.064</mixed-citation><mixed-citation xml:lang="en">Romanov A., Cherniavskiy A., Novikova N., et al. Pulmonary Artery Denervation for Patients With Residual Pulmonary Hypertension After Pulmonary Endarterectomy. JACC 2020; 76 (8): 916-26. DOI: 10.1016/j.jacc.2020.06.064</mixed-citation></citation-alternatives></ref><ref id="cit92"><label>92</label><citation-alternatives><mixed-citation xml:lang="ru">Saouti N, Morshuis WJ, Heijmen RH, Snijder RJ. Long-term outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: a single institution experience. Eur J Cardiothorac Surg. 2009; 35:947–952. doi: 10.1016/j.ejcts.2009.01.023.</mixed-citation><mixed-citation xml:lang="en">Saouti N, Morshuis WJ, Heijmen RH, Snijder RJ. Long-term outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: a single institution experience. Eur J Cardiothorac Surg. 2009; 35:947–952. doi: 10.1016/j.ejcts.2009.01.023.</mixed-citation></citation-alternatives></ref><ref id="cit93"><label>93</label><citation-alternatives><mixed-citation xml:lang="ru">Shah S., Boyd G., Pyne C.T., et al. Right heart catheterization using antecubital venous access: feasibility, safety and adoption rate in a tertiary center. Catheter Cardiovasc Interv 2014; 84 (1): 70-74. DOI: 10.1002/ccd.25249</mixed-citation><mixed-citation xml:lang="en">Shah S., Boyd G., Pyne C.T., et al. Right heart catheterization using antecubital venous access: feasibility, safety and adoption rate in a tertiary center. Catheter Cardiovasc Interv 2014; 84 (1): 70-74. DOI: 10.1002/ccd.25249</mixed-citation></citation-alternatives></ref><ref id="cit94"><label>94</label><citation-alternatives><mixed-citation xml:lang="ru">Simonneau G., D’Armini A.M., Ghofrani H.A., et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a longterm extension study (CHEST-2). Eur Respir J, 2015 May, 45(5): 1293-302. DOI: 10.1183/09031936.00087114</mixed-citation><mixed-citation xml:lang="en">Simonneau G., D’Armini A.M., Ghofrani H.A., et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a longterm extension study (CHEST-2). Eur Respir J, 2015 May, 45(5): 1293-302. DOI: 10.1183/09031936.00087114</mixed-citation></citation-alternatives></ref><ref id="cit95"><label>95</label><citation-alternatives><mixed-citation xml:lang="ru">Skoro-Sajer N., Marta G., Gerges C., et al. Surgical specimens, haemodynamics and long-term outcomes after pulmonary endarterectomy. Thorax 2014;.69:116–122. DOI: 10.1136/thoraxjnl-2013-203746</mixed-citation><mixed-citation xml:lang="en">Skoro-Sajer N., Marta G., Gerges C., et al. Surgical specimens, haemodynamics and long-term outcomes after pulmonary endarterectomy. Thorax 2014;.69:116–122. DOI: 10.1136/thoraxjnl-2013-203746</mixed-citation></citation-alternatives></ref><ref id="cit96"><label>96</label><citation-alternatives><mixed-citation xml:lang="ru">Stasch J.P., et al. Soluble Guanylate Cyclase as an Emerging Therapeutic Target in Cardiopulmonary Disease. Circulation 2011; 123: 2263-2274. DOI: 10.1161/CIRCULATIONAHA.110.981738</mixed-citation><mixed-citation xml:lang="en">Stasch J.P., et al. Soluble Guanylate Cyclase as an Emerging Therapeutic Target in Cardiopulmonary Disease. Circulation 2011; 123: 2263-2274. DOI: 10.1161/CIRCULATIONAHA.110.981738</mixed-citation></citation-alternatives></ref><ref id="cit97"><label>97</label><citation-alternatives><mixed-citation xml:lang="ru">Sugimura K, Fukumoto Y, Satoh K., et al. Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long-term prognosis in patients with chronic thromboembolic pulmonary hypertension. Circ J 2012; 76: 485– 488. DOI: 10.1253/circj.cj-11-1217</mixed-citation><mixed-citation xml:lang="en">Sugimura K, Fukumoto Y, Satoh K., et al. Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long-term prognosis in patients with chronic thromboembolic pulmonary hypertension. Circ J 2012; 76: 485– 488. DOI: 10.1253/circj.cj-11-1217</mixed-citation></citation-alternatives></ref><ref id="cit98"><label>98</label><citation-alternatives><mixed-citation xml:lang="ru">Sugiyama M., Fukuda T., Sanda Y., et al. Organized thrombus in pulmonary arteries in patients with chronic thromboembolic pulmonary hypertension; imaging with cone beam computed tomography. Jpn J Radiol 2014; 32:375 – 382. DOI: 10.1007/s11604-014-0319-8</mixed-citation><mixed-citation xml:lang="en">Sugiyama M., Fukuda T., Sanda Y., et al. Organized thrombus in pulmonary arteries in patients with chronic thromboembolic pulmonary hypertension; imaging with cone beam computed tomography. Jpn J Radiol 2014; 32:375 – 382. DOI: 10.1007/s11604-014-0319-8</mixed-citation></citation-alternatives></ref><ref id="cit99"><label>99</label><citation-alternatives><mixed-citation xml:lang="ru">Surie S, Tijssen MA, Biervliet JD et al. Chorea in adults following pulmonary endarterectomy. Mov Disord. 2010 Jun 15;25(8):1101-4. DOI: 10.1002/mds.23044</mixed-citation><mixed-citation xml:lang="en">Surie S, Tijssen MA, Biervliet JD et al. Chorea in adults following pulmonary endarterectomy. Mov Disord. 2010 Jun 15;25(8):1101-4. DOI: 10.1002/mds.23044</mixed-citation></citation-alternatives></ref><ref id="cit100"><label>100</label><citation-alternatives><mixed-citation xml:lang="ru">Suntharalingam J., Treacy C.M., Doughty N.J., et al. Long-term use of sildenafil in inoperable chronic thromboembolic pulmonary hypertension. Chest 2008; 134: 229–2. https://doi.org/10.1378/chest.07-2681</mixed-citation><mixed-citation xml:lang="en">Suntharalingam J., Treacy C.M., Doughty N.J., et al. Long-term use of sildenafil in inoperable chronic thromboembolic pulmonary hypertension. Chest 2008; 134: 229–2. https://doi.org/10.1378/chest.07-2681</mixed-citation></citation-alternatives></ref><ref id="cit101"><label>101</label><citation-alternatives><mixed-citation xml:lang="ru">Taboada D, Pepke-Zaba J, Jenkins DP, et al. Outcome of pulmonary endarterectomy in symptomatic chronic thromboembolic disease. Eur Respir J 2014; 44: 1635–1645. DOI: 10.1183/09031936.00050114</mixed-citation><mixed-citation xml:lang="en">Taboada D, Pepke-Zaba J, Jenkins DP, et al. Outcome of pulmonary endarterectomy in symptomatic chronic thromboembolic disease. Eur Respir J 2014; 44: 1635–1645. DOI: 10.1183/09031936.00050114</mixed-citation></citation-alternatives></ref><ref id="cit102"><label>102</label><citation-alternatives><mixed-citation xml:lang="ru">Taran I., Belevskaya A.A., Saidova M.A., Martynyuk T.V., Chazova I.E. Initial Riociguat Monotherapy and Transition from Sildenafil to Riociguat in Patients with Idiopathic Pulmonary Arterial Hypertension: Influence on Right Heart Remodeling and Right Ventricular–Pulmonary Arterial Coupling. Lung 2018; 196:745–753. DOI: 10.1007/s00408-018-0160-4</mixed-citation><mixed-citation xml:lang="en">Taran I., Belevskaya A.A., Saidova M.A., Martynyuk T.V., Chazova I.E. Initial Riociguat Monotherapy and Transition from Sildenafil to Riociguat in Patients with Idiopathic Pulmonary Arterial Hypertension: Influence on Right Heart Remodeling and Right Ventricular–Pulmonary Arterial Coupling. Lung 2018; 196:745–753. DOI: 10.1007/s00408-018-0160-4</mixed-citation></citation-alternatives></ref><ref id="cit103"><label>103</label><citation-alternatives><mixed-citation xml:lang="ru">Taran I., Valieva Z.S., Belevskaya A.A., Saidova M.A., Martynyuk T.V., Chazova I.E. Features of the disease in patients with precapillary pulmonary hypertension with essential hypertension and carbonhydrate metabolism disorders. Journal of Hypertension 2019; 37: e203. doi: 10.1097/01.hjh.0000572616.51506.ca.</mixed-citation><mixed-citation xml:lang="en">Taran I., Valieva Z.S., Belevskaya A.A., Saidova M.A., Martynyuk T.V., Chazova I.E. Features of the disease in patients with precapillary pulmonary hypertension with essential hypertension and carbonhydrate metabolism disorders. Journal of Hypertension 2019; 37: e203. doi: 10.1097/01.hjh.0000572616.51506.ca.</mixed-citation></citation-alternatives></ref><ref id="cit104"><label>104</label><citation-alternatives><mixed-citation xml:lang="ru">Tsai C.H., Wu C.K., Kuo P.H., et al. Riociguat Improves Pulmonary Hemodynamics in Patients with Inoperable Chronic Thromboembolic Pulmonary Hypertension. Аcta Cardiol. Sin 2020; 36 (1): 64-71. DOI: 10.6515/ACS.202001_36(1).20190612A</mixed-citation><mixed-citation xml:lang="en">Tsai C.H., Wu C.K., Kuo P.H., et al. Riociguat Improves Pulmonary Hemodynamics in Patients with Inoperable Chronic Thromboembolic Pulmonary Hypertension. Аcta Cardiol. Sin 2020; 36 (1): 64-71. DOI: 10.6515/ACS.202001_36(1).20190612A</mixed-citation></citation-alternatives></ref><ref id="cit105"><label>105</label><citation-alternatives><mixed-citation xml:lang="ru">Tunariu N., Gibbs S., Win Z., et al. Ventilation-perfusion scintigraphy Is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension. J Nucl Med 2007;48:680–684. DOI: 10.2967/jnumed.106.039438</mixed-citation><mixed-citation xml:lang="en">Tunariu N., Gibbs S., Win Z., et al. Ventilation-perfusion scintigraphy Is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension. J Nucl Med 2007;48:680–684. DOI: 10.2967/jnumed.106.039438</mixed-citation></citation-alternatives></ref><ref id="cit106"><label>106</label><citation-alternatives><mixed-citation xml:lang="ru">van Thor M.C., Ten Klooster L., Snijder R.J., et al. Long-term clinical value and outcome of riociguat in chronic thromboembolic pulmonary hypertension. Int J Cardiol Heart Vasc 2019; 22: 163-168. DOI: 10.1016/j.ijcha.2019.02.004</mixed-citation><mixed-citation xml:lang="en">van Thor M.C., Ten Klooster L., Snijder R.J., et al. Long-term clinical value and outcome of riociguat in chronic thromboembolic pulmonary hypertension. Int J Cardiol Heart Vasc 2019; 22: 163-168. DOI: 10.1016/j.ijcha.2019.02.004</mixed-citation></citation-alternatives></ref><ref id="cit107"><label>107</label><citation-alternatives><mixed-citation xml:lang="ru">Wagenvoort C.A. Pathology of pulmonary thromboembolism. Chest 1995; 107: 10S–17S. DOI: 10.1378/chest.107.1_supplement.10s</mixed-citation><mixed-citation xml:lang="en">Wagenvoort C.A. Pathology of pulmonary thromboembolism. Chest 1995; 107: 10S–17S. DOI: 10.1378/chest.107.1_supplement.10s</mixed-citation></citation-alternatives></ref><ref id="cit108"><label>108</label><citation-alternatives><mixed-citation xml:lang="ru">Wilkens H, Lang I, Behr J, et al. Chronic thromboembolic pulmonary hypertension: Recommendations from the Cologne Consensus Conference 2010.Dtsch Med Wochenschr 2010;135(Suppl 3):S125–30 https://doi.org/10.1016/S0167-5273(11)70493-4</mixed-citation><mixed-citation xml:lang="en">Wilkens H, Lang I, Behr J, et al. Chronic thromboembolic pulmonary hypertension: Recommendations from the Cologne Consensus Conference 2010.Dtsch Med Wochenschr 2010;135(Suppl 3):S125–30 https://doi.org/10.1016/S0167-5273(11)70493-4</mixed-citation></citation-alternatives></ref><ref id="cit109"><label>109</label><citation-alternatives><mixed-citation xml:lang="ru">Wilkens, et al. Chronic thromboembolic pulmonary hypertension (CTEPH): Updated recommendations from the Cologne Consensus Conference 2018. Int. J. Cardiol. 2018; 272: 69-78. DOI: 10.1016/j.ijcard.2018.08.079</mixed-citation><mixed-citation xml:lang="en">Wilkens, et al. Chronic thromboembolic pulmonary hypertension (CTEPH): Updated recommendations from the Cologne Consensus Conference 2018. Int. J. Cardiol. 2018; 272: 69-78. DOI: 10.1016/j.ijcard.2018.08.079</mixed-citation></citation-alternatives></ref><ref id="cit110"><label>110</label><citation-alternatives><mixed-citation xml:lang="ru">Yamamoto K., Tanabe N., Suda R., et al. Riociguat for patients with chronic thromboembolic pulmonary hypertension: Usefulness of transitioning from phosphodiesterase type 5 inhibitor. Respir Investig 2017; 55 (4): P.270-275. https://doi.org/10.1016/j.resinv.2017.04.004</mixed-citation><mixed-citation xml:lang="en">Yamamoto K., Tanabe N., Suda R., et al. Riociguat for patients with chronic thromboembolic pulmonary hypertension: Usefulness of transitioning from phosphodiesterase type 5 inhibitor. Respir Investig 2017; 55 (4): P.270-275. https://doi.org/10.1016/j.resinv.2017.04.004</mixed-citation></citation-alternatives></ref><ref id="cit111"><label>111</label><citation-alternatives><mixed-citation xml:lang="ru">Zhai Z, Murphy K, Tighe H,et al. Differences in ventilatory inefficiency between pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Chest 2011; 140: 1284–1291. https://doi.org/10.1378/chest.10-3357</mixed-citation><mixed-citation xml:lang="en">Zhai Z, Murphy K, Tighe H,et al. Differences in ventilatory inefficiency between pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Chest 2011; 140: 1284–1291. https://doi.org/10.1378/chest.10-3357</mixed-citation></citation-alternatives></ref><ref id="cit112"><label>112</label><citation-alternatives><mixed-citation xml:lang="ru">Zoreka et al. Pulmonary Capillary Wedge Pressure Measurement: A Challenge for Diagnosis of Pulmonary Arterial Hypertension. Int J Respir Pulm Med 2015; 2: 010.</mixed-citation><mixed-citation xml:lang="en">Zoreka et al. Pulmonary Capillary Wedge Pressure Measurement: A Challenge for Diagnosis of Pulmonary Arterial Hypertension. Int J Respir Pulm Med 2015; 2: 010.</mixed-citation></citation-alternatives></ref><ref id="cit113"><label>113</label><citation-alternatives><mixed-citation xml:lang="ru">AMBER-1. https://clinicaltrials.gov/ct2/show/NCT01884675/</mixed-citation><mixed-citation xml:lang="en">AMBER-1. https://clinicaltrials.gov/ct2/show/NCT01884675/</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
